153 related articles for article (PubMed ID: 19032773)
21. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.
Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH
Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223
[TBL] [Abstract][Full Text] [Related]
22. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study.
Benedetti-Panici P; Maneschi F; D'Andrea G; Cutillo G; Rabitti C; Congiu M; Coronetta F; Capelli A
Cancer; 2000 May; 88(10):2267-74. PubMed ID: 10820348
[TBL] [Abstract][Full Text] [Related]
23. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
[TBL] [Abstract][Full Text] [Related]
24. How important is removal of the parametrium at surgery for carcinoma of the cervix?
Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
Gynecol Oncol; 2002 Jan; 84(1):145-9. PubMed ID: 11748991
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study.
Twu NF; Ou YC; Liao CI; Chang WY; Yang LY; Tang YH; Chen TC; Chen CH; Chen TH; Yeh LS; Hsu ST; Chen YC; Chang CC; Cheng YM; Huang CY; Liu FS; Lin YS; Hsiao SM; Kan YY; Lai CH
Surg Oncol; 2016 Sep; 25(3):229-35. PubMed ID: 27566027
[TBL] [Abstract][Full Text] [Related]
26. Retrospective analysis for predictors of parametrial involvement in IB cervical cancer.
Kubota S; Kobayashi E; Kakuda M; Matsuzaki S; Ueda Y; Yoshino K; Kimura T
J Obstet Gynaecol Res; 2019 Mar; 45(3):679-685. PubMed ID: 30565810
[TBL] [Abstract][Full Text] [Related]
27. [Contrast ultrasound using SonoVue for pelvic radiation with concurrent chemotherapy monitoring in stage IB-II cervical cancer].
Marret H; Barillot I; Rolland Y; Lévèque J
Cancer Radiother; 2009 Oct; 13(6-7):515-9. PubMed ID: 19726215
[TBL] [Abstract][Full Text] [Related]
28. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
[TBL] [Abstract][Full Text] [Related]
29. Clinical and pathological characteristics related to parametrial involvement in clinical early-stage cervical cancer.
Boyraz G; Basaran D; Salman MC; Ozgul N; Yuce K
Ginekol Pol; 2016; 87(6):417-21. PubMed ID: 27418217
[TBL] [Abstract][Full Text] [Related]
30. Which factors predict parametrial involvement in early stage cervical cancer? A Turkish multicenter study.
Kilic C; Cakir C; Yuksel D; Tokgozoglu N; Comert GK; Karalok A; Ureyen I; Turkmen O; Boyraz G; Tasci T; Tekin OM; Turan T
Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():63-66. PubMed ID: 31675631
[TBL] [Abstract][Full Text] [Related]
31. Intratumoral lymphatic vessel density and clinicopathologic features of patients with early-stage cervical cancer after radical hysterectomy.
Zaganelli FL; Carvalho FM; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP
Int J Gynecol Cancer; 2010 Oct; 20(7):1225-31. PubMed ID: 21135594
[TBL] [Abstract][Full Text] [Related]
32. Transvaginal color Doppler ultrasound for monitoring the response to neoadjuvant chemotherapy in advanced cervical cancer.
Greco P; Cormio G; Vimercati A; Nacci G; di Vagno G; Loverro G; Selvaggi L
Acta Obstet Gynecol Scand; 1997 Feb; 76(2):169-72. PubMed ID: 9049292
[TBL] [Abstract][Full Text] [Related]
33. Intratumoral blood flow analysis in endometrial carcinoma: correlation with tumor characteristics and risk for recurrence.
Alcázar JL; Galán MJ; Jurado M; López-García G
Gynecol Oncol; 2002 Feb; 84(2):258-62. PubMed ID: 11812084
[TBL] [Abstract][Full Text] [Related]
34. What is the risk for parametrial involvement in women with early-stage cervical cancer with tumour <20 mm and with negative sentinel lymph nodes?
Klat J; Sevcik L; Simetka O; Graf P; Dvorackova J; Kraft O
Aust N Z J Obstet Gynaecol; 2012 Dec; 52(6):540-4. PubMed ID: 23216324
[TBL] [Abstract][Full Text] [Related]
35. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy.
Wright JD; Grigsby PW; Brooks R; Powell MA; Gibb RK; Gao F; Rader JS; Mutch DG
Cancer; 2007 Sep; 110(6):1281-6. PubMed ID: 17654664
[TBL] [Abstract][Full Text] [Related]
36. Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapy.
Kim H; Cho WK; Kim YJ; Kim YS; Park W
Gynecol Oncol; 2020 May; 157(2):423-428. PubMed ID: 32139148
[TBL] [Abstract][Full Text] [Related]
37. Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer.
Frumovitz M; Sun CC; Schmeler KM; Deavers MT; Dos Reis R; Levenback CF; Ramirez PT
Obstet Gynecol; 2009 Jul; 114(1):93-99. PubMed ID: 19546764
[TBL] [Abstract][Full Text] [Related]
38. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer.
Memarzadeh S; Natarajan S; Dandade DP; Ostrzega N; Saber PA; Busuttil A; Lentz SE; Berek JS
Obstet Gynecol; 2003 Sep; 102(3):612-9. PubMed ID: 12962952
[TBL] [Abstract][Full Text] [Related]
39. Correlations of p53 expression with transvaginal color Doppler ultrasound findings of cervical cancer after radiotherapy.
Wang P; Sun W; Wang L; Gao J; Zhang J; He P
J BUON; 2018; 23(3):769-775. PubMed ID: 30003750
[TBL] [Abstract][Full Text] [Related]
40. Surgical pathologic factors in patients with early-stage cervical carcinoma treated with radical hysterectomy and pelvic lymph node dissection: association with administration of adjuvant radiotherapy and effect on survival.
Piura B; Rabinovich A; Friger M
Eur J Gynaecol Oncol; 2006; 27(6):573-8. PubMed ID: 17290585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
